HIV molecular immunology database
Found 26 matching records:
HXB2 Location | Gag(77-85) | Gag Epitope Map
View variants at this location |
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
SLYNTVATL
|
Epitope Alignment | |||||||||||||||||||
Variants |
|
||||||||||||||||||||
Epitope Name | Gag 77 | ||||||||||||||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 6 variant(s).
Variant ID. | 1658 |
---|---|
Epitope Seq. | SLYNTVATL |
Variant Seq. | SLfNTVATL |
Mutations | Y/F |
Epitope Location | Y3F |
HXB2 Location | Y79F |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt15, Pt18 carried this variant epitope, but cross-recognized the challenge HXB2 sequence SLYNTVATL. Subject Pt30 who carried the challenge epitope too did not recognize that HXB2 sequence. |
Variant ID. | 1660 |
---|---|
Epitope Seq. | SLYNTVATL |
Variant Seq. | SLYNTVAvL |
Mutations | T/V |
Epitope Location | T8V |
HXB2 Location | T84V |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject P43 carried this variant epitope, but cross-recognized the challenge HXB2 sequence SLYNTVATL. Subject Pt21 who also carried the variant epitope did not recognize HXB2 sequence. |
Variant ID. | 1661 |
---|---|
Epitope Seq. | SLYNTVATL |
Variant Seq. | SLYNTVATi |
Mutations | L/I |
Epitope Location | L9I |
HXB2 Location | L85I |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt23 carried this variant epitope, and recognized the challenge HXB2 sequence SLYNTVATL. |
Variant ID. | 1662 |
---|---|
Epitope Seq. | SLYNTVATL |
Variant Seq. | SLfNTVATi |
Mutations | Y/F L/I |
Epitope Location | Y3F L9I |
HXB2 Location | Y79F L85I |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt41 carried this variant epitope, and recognized the challenge HXB2 sequence SLYNTVATL. |
Variant ID. | 1663 |
---|---|
Epitope Seq. | SLYNTVATL |
Variant Seq. | SLnNaiAvL |
Mutations | Y/N T/A V/I T/V |
Epitope Location | Y3N T5A V6I T8V |
HXB2 Location | Y79N T81A V82I T84V |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt17 carried this variant epitope, and did not recognize the challenge HXB2 sequence SLYNTVATL. |
Variant ID. | 2264 |
---|---|
Epitope Seq. | SLYNTVATL |
Variant Seq. | SvYNTVATL |
Mutations | L/V |
Epitope Location | L2V |
HXB2 Location | L78V |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt33 carried this variant, and did not recognize the challenge HXB2 SLYNTVATL. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Gag(80-88) | Gag Epitope Map
View variants at this location |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
NTVATLYCV
|
Epitope Alignment | |||||||||||||
Variants |
|
||||||||||||||
Epitope Name | Gag 80 | ||||||||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 4 variant(s).
Variant ID. | 1664 |
---|---|
Epitope Seq. | NTVATLYCV |
Variant Seq. | NaiAvLYCV |
Mutations | T/A V/I T/V |
Epitope Location | T2A V3I T5V |
HXB2 Location | T81A V82I T84V |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt15, Pt16, Pt18, Pt30, Pt33 and Pt35 carried this HXB2 epitope. All of the above were unable to recognize it however, except for Pt15 who did recognize the HXB2 sequence. Only Pt17 carried the variant NaiAvLYCV and was unable to cross-recognize the challenge HXB2 sequence. |
Variant ID. | 1665 |
---|---|
Epitope Seq. | NTVATLYCV |
Variant Seq. | NTVAvLYCV |
Mutations | T/V |
Epitope Location | T5V |
HXB2 Location | T84V |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt21 and Pt43 carried this variant and were unable to recognize the challenge HXB2 form, NTVATLYCV. |
Variant ID. | 1666 |
---|---|
Epitope Seq. | NTVATLYCV |
Variant Seq. | NTVATiYCV |
Mutations | L/I |
Epitope Location | L6I |
HXB2 Location | L85I |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt23 and Pt41 carried this variant and were unable to recognize the challenge HXB2 form, NTVATLYCV. |
Variant ID. | 1667 |
---|---|
Epitope Seq. | NTVATLYCV |
Variant Seq. | NTVATLYCV |
Mutations | |
Epitope Location | |
HXB2 Location | |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt21 carried this variant and was unable to recognize the challenge HXB2 form, NTVATLYCV. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Gag(242-250) | Gag Epitope Map
View variants at this location |
|||||||
---|---|---|---|---|---|---|---|---|---|
Epitope |
TLQEQIGWM
|
Epitope Alignment | |||||||
Variants |
|
||||||||
Epitope Name | Gag 242 | ||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 2 variant(s).
Variant ID. | 1668 |
---|---|
Epitope Seq. | TLQEQIGWM |
Variant Seq. | TLQEQIaWM |
Mutations | G/A |
Epitope Location | G7A |
HXB2 Location | G248A |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt15 and Pt33 carried this variant and were unable to recognize the challenge HXB2 form. Subjects Pt35 and Pt41 carried the HXB2 sequence and were able to recognize it; all others Pt16, Pt17, Pt18, Pt21, Pt23 and Pt35 did carry the HXB2 epitope, but could not recognize it. |
Variant ID. | 1669 |
---|---|
Epitope Seq. | TLQEQIGWM |
Variant Seq. | nLQEQIGWM |
Mutations | T/N |
Epitope Location | T1N |
HXB2 Location | T242N |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt30 carried this variant and was unable to recognize the challenge HXB2 form, NTVATLYCV. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Gag(362-370) | Gag Epitope Map
View variants at this location |
|||||||
---|---|---|---|---|---|---|---|---|---|
Epitope |
VLAEAMSQV
|
Epitope Alignment | |||||||
Variants |
|
||||||||
Epitope Name | Gag 362(9V) | ||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 2 variant(s).
Variant ID. | 1690 |
---|---|
Epitope Seq. | VLAEAMSQV |
Variant Seq. | VLAEAMSQa |
Mutations | V/A |
Epitope Location | V9A |
HXB2 Location | V370A |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt15 carried this variant and was unable to recognize either variant or the challenge HXB2 form, VLAEAMSQV. |
Variant ID. | 1691 |
---|---|
Epitope Seq. | VLAEAMSQV |
Variant Seq. | VLAEAMSQm |
Mutations | V/M |
Epitope Location | V9M |
HXB2 Location | V370M |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt17 carried this variant and was unable to recognize either variant or the challenge HXB2 form, VLAEAMSQV. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Gag(433-440) | Gag Epitope Map
View variants at this location |
|||||||
---|---|---|---|---|---|---|---|---|---|
Epitope |
FLGKIWPS
|
Epitope Alignment | |||||||
Variants |
|
||||||||
Epitope Name | Gag 433 | ||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 2 variant(s).
Variant ID. | 1692 |
---|---|
Epitope Seq. | FLGKIWPS |
Variant Seq. | FLGKIWsS |
Mutations | P/S |
Epitope Location | P7S |
HXB2 Location | P439S |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt16 carried this variant and was able to cross-recognize the challenge HXB2 epitope, FLGKIWPS. Of the 9 subjects that did carry the HXB2 epitope sequence, only 3, Pt30, Pt33 and Pt41 were able to recognize it. |
Variant ID. | 1693 |
---|---|
Epitope Seq. | FLGKIWPS |
Variant Seq. | FLGrIWPS |
Mutations | K/R |
Epitope Location | K4R |
HXB2 Location | K436R |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt43 carried this variant and was able to cross-recognize the challenge HXB2 epitope, FLGKIWPS. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Pol(59-67) | Pol Epitope Map
View variants at this location |
|||||||
---|---|---|---|---|---|---|---|---|---|
Epitope |
ITLWQRPLV
|
Epitope Alignment | |||||||
Variants |
|
||||||||
Epitope Name | Pol 59 | ||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 2 variant(s).
Variant ID. | 1670 |
---|---|
Epitope Seq. | ITLWQRPLV |
Variant Seq. | ITLWQRPiV |
Mutations | L/I |
Epitope Location | L8I |
HXB2 Location | L66I |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt21 carried this variant and was unable to recognize the challenge HXB2 epitope form, ITLWQRPLV. |
Variant ID. | 1671 |
---|---|
Epitope Seq. | ITLWQRPLV |
Variant Seq. | ITLWQRPfV |
Mutations | L/F |
Epitope Location | L8F |
HXB2 Location | L66F |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt41 carried this variant and was unable to recognize the challenge HXB2 epitope form, ITLWQRPLV. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Pol(464-472) | Pol Epitope Map
View variants at this location |
|||||||
---|---|---|---|---|---|---|---|---|---|
Epitope |
ILKEPVHGV
|
Epitope Alignment | |||||||
Variants |
|
||||||||
Epitope Name | Pol 476 | ||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 2 variant(s).
Variant ID. | 1759 |
---|---|
Epitope Seq. | ILKEPVHGV |
Variant Seq. | ILKEPVHGa |
Mutations | V/A |
Epitope Location | V9A |
HXB2 Location | V472A |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt18 carried this variant epitope, and did not recognize the challenge HXB2 ILKEPVHGV. |
Variant ID. | 1760 |
---|---|
Epitope Seq. | ILKEPVHGV |
Variant Seq. | IiKEPVHxx |
Mutations | L/I G/X V/X |
Epitope Location | L2I G8X V9X |
HXB2 Location | L465I G471X V472X |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt41 carried this variant epitope, and did not recognize the challenge HXB2 ILKEPVHGV. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Pol(571-578) | Pol Epitope Map
View variants at this location |
||||
---|---|---|---|---|---|---|
Epitope |
FVNTPPLV
|
Epitope Alignment | ||||
Variants |
|
|||||
Epitope Name | Pol 571 | |||||
Species (MHC/HLA) | human(A2) |
Showing all: 1 variant(s).
Variant ID. | 1672 |
---|---|
Epitope Seq. | FVNTPPLV |
Variant Seq. | FVNTPlLV |
Mutations | P/L |
Epitope Location | P6L |
HXB2 Location | P576L |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt18 carried this variant and was unable to recognize the challenge HXB2 epitope form, FVNTPPLV. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Pol(606-614) | Pol Epitope Map
View variants at this location |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
KLGKAGYVT
|
Epitope Alignment | |||||||||||||
Variants |
|
||||||||||||||
Epitope Name | Pol 606 | ||||||||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 4 variant(s).
Variant ID. | 1694 |
---|---|
Epitope Seq. | KLGKAGYVT |
Variant Seq. | KLGKAGYVv |
Mutations | T/V |
Epitope Location | T9V |
HXB2 Location | T614V |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Though poorly immunogenic in A2 transgenic mice, anchor-optimization of HXB2 Pol 606(9T) to variant Pol606(9V), KLGKAGYVv, induced cross-reaction and higher immunogenicity. |
Variant ID. | 1695 |
---|---|
Epitope Seq. | KLGKAGYVT |
Variant Seq. | KmGKAGYVT |
Mutations | L/M |
Epitope Location | L2M |
HXB2 Location | L607M |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt15 and Pt35 carried this variant, but while Pt15 was unable to cross-recognize the challenge HXB2 sequence KLGKAGYVT, Pt35 did recognize this challenge HXB2 sequence. |
Variant ID. | 1696 |
---|---|
Epitope Seq. | KLGKAGYVT |
Variant Seq. | KtGKAGYVT |
Mutations | L/T |
Epitope Location | L2T |
HXB2 Location | L607T |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt16 carried this variant and was unable to cross-recognize the challenge HXB2 epitope, KLGKAGYVT. |
Variant ID. | 1697 |
---|---|
Epitope Seq. | KLGKAGYVT |
Variant Seq. | KiGKAGYVT |
Mutations | L/I |
Epitope Location | L2I |
HXB2 Location | L607I |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt17 carried this variant and was unable to cross-recognize the challenge HXB2 epitope, KLGKAGYVT. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Pol(687-695) | Pol Epitope Map
View variants at this location |
||||
---|---|---|---|---|---|---|
Epitope |
YLAWVPAHK
|
Epitope Alignment | ||||
Variants |
|
|||||
Epitope Name | Pol 687 | |||||
Species (MHC/HLA) | human(A2) |
Showing all: 1 variant(s).
Variant ID. | 1673 |
---|---|
Epitope Seq. | YLAWVPAHK |
Variant Seq. | YLsWVPAHK |
Mutations | A/S |
Epitope Location | A3S |
HXB2 Location | A689S |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt15 carried this variant epitope in a structural protein, and did not recognize the challenge HXB2 epitope form, YLAWVPAHK. 10 other subjects were HXB2 epitope carriers, but of them only Pt16 could recognize that epitope. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Vif(23-31) | Vif Epitope Map
View variants at this location |
|||||||
---|---|---|---|---|---|---|---|---|---|
Epitope |
SLVKHHMYI
|
Epitope Alignment | |||||||
Variants |
|
||||||||
Epitope Name | VIf 23(9I) | ||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 2 variant(s).
Variant ID. | 1698 |
---|---|
Epitope Seq. | SLVKHHMYI |
Variant Seq. | SLVKHHMYv |
Mutations | I/V |
Epitope Location | I9V |
HXB2 Location | I31V |
Mutation Type | SF: susceptible form |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | This 9I variant and 9V consensus epitope cross-reacted in A2 transgenic mice. Subjects Pt18 and Pt41 carried the HXB2 epitope SLVKHHMYV and were unable to recognize either the HXB2 or 9I variant form. Subjects Pt17, Pt23 and Pt43 carried the 9I variant form, and while Pt17 and Pt23 were unable to recognize either form, Pt 43 was able to recognize both the consensus and 9I variant. |
Variant ID. | 1699 |
---|---|
Epitope Seq. | SLVKHHMYI |
Variant Seq. | SvVKHHMYI |
Mutations | L/V |
Epitope Location | L2V |
HXB2 Location | L24V |
Mutation Type | SF: susceptible form |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | This 2V variant was the most immunogenic of all epitopes studied and it cross-reacted with the 9I variant, SLVKHHMYi. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Vif(101-109) | Vif Epitope Map
View variants at this location |
|||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
GLADQLIHL
|
Epitope Alignment | |||||||||||||||||||||||||
Variants |
|
||||||||||||||||||||||||||
Epitope Name | VIf 101(9L) | ||||||||||||||||||||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 8 variant(s).
Variant ID. | 1700 |
---|---|
Epitope Seq. | GLADQLIHL |
Variant Seq. | nLADQLIHL |
Mutations | G/N |
Epitope Location | G1N |
HXB2 Location | G101N |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt16, Pt17 carried this variant and were unable to recognize the 9M variant GLADQLIHL. Pt 17 also did not recognize the challenge 9L HXB2 epitope, but Pt16 did recognize it. |
Variant ID. | 1701 |
---|---|
Epitope Seq. | GLADQLIHL |
Variant Seq. | dLADhLIHL |
Mutations | G/D Q/H |
Epitope Location | G1D Q5H |
HXB2 Location | G101D Q105H |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt18 carried this variant and was unable to recognize both the 9L HXB2 epitope GLADQLIHL, as well as the 9M variant GLADQLIHM. |
Variant ID. | 1702 |
---|---|
Epitope Seq. | GLADQLIHL |
Variant Seq. | dLADQLIHL |
Mutations | G/D |
Epitope Location | G1D |
HXB2 Location | G101D |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt 21, Pt23, Pt33 carried this variant and were unable to recognize the 9M variant GLADQLIHM. Pt21 and Pt33 were also unable to recognize the HXB2 epitope GLADQLIHL, but Pt23 was able to recognize it. |
Variant ID. | 1703 |
---|---|
Epitope Seq. | GLADQLIHL |
Variant Seq. | evADQLIHL |
Mutations | G/E L/V |
Epitope Location | G1E L2V |
HXB2 Location | G101E L102V |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt30 carried this variant and did not recognize either the challenge HXB2 epitope GLADQLIHL, or the 9M variant GLADQLIHM. |
Variant ID. | 1704 |
---|---|
Epitope Seq. | GLADQLIHL |
Variant Seq. | sLADQLIHL |
Mutations | G/S |
Epitope Location | G1S |
HXB2 Location | G101S |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt35 carried this variant and did not recognize either the challenge HXB2 epitope GLADQLIHL, or the 9M variant GLADQLIHM. |
Variant ID. | 1705 |
---|---|
Epitope Seq. | GLADQLIHL |
Variant Seq. | GLADrLIHL |
Mutations | Q/R |
Epitope Location | Q5R |
HXB2 Location | Q105R |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt43 carried this variant and did not recognize either the challenge HXB2 epitope GLADQLIHL, or the 9M variant GLADQLIHM. |
Variant ID. | 1706 |
---|---|
Epitope Seq. | GLADQLIHL |
Variant Seq. | hLADQLIHq |
Mutations | G/H L/Q |
Epitope Location | G1H L9Q |
HXB2 Location | G101H L109Q |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt41 carried this variant and did not recognize the challenge HXB2 epitope GLADQLIHL, however it did recognize the 9M variant GLADQLIHM. |
Variant ID. | 1707 |
---|---|
Epitope Seq. | GLADQLIHL |
Variant Seq. | GLADQLIHm |
Mutations | L/M |
Epitope Location | L9M |
HXB2 Location | L109M |
Mutation Type | SF: susceptible form |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt41 carried hLADQLIHq variant and did not recognize the challenge HXB2 epitope GLADQLIHL, however it did recognize the 9M variant GLADQLIHm. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Vif(149-157) | Vif Epitope Map
View variants at this location |
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
ALAALITPK
|
Epitope Alignment | ||||||||||||||||||||||
Variants |
|
|||||||||||||||||||||||
Epitope Name | VIf 149 | |||||||||||||||||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 7 variant(s).
Variant ID. | 1679 |
---|---|
Epitope Seq. | ALAALITPK |
Variant Seq. | ALtALITPK |
Mutations | A/T |
Epitope Location | A3T |
HXB2 Location | A151T |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt18, Pt30 carried this variant and were unable to recognize the challenge HXB2 form, ALAALITPK. |
Variant ID. | 1680 |
---|---|
Epitope Seq. | ALAALITPK |
Variant Seq. | ALtALIkPK |
Mutations | A/T T/K |
Epitope Location | A3T T7K |
HXB2 Location | A151T T155K |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt15 carried this variant and was unable to recognize the challenge HXB2 form, ALAALITPK. |
Variant ID. | 1681 |
---|---|
Epitope Seq. | ALAALITPK |
Variant Seq. | ltAALtkPK |
Mutations | A/L L/T I/T T/K |
Epitope Location | A1L L2T I6T T7K |
HXB2 Location | A149L L150T I154T T155K |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt21 carried this variant and was unable to recognize the challenge HXB2 form, ALAALITPK. |
Variant ID. | 1682 |
---|---|
Epitope Seq. | ALAALITPK |
Variant Seq. | ALtALIatK |
Mutations | A/T T/A P/T |
Epitope Location | A3T T7A P8T |
HXB2 Location | A151T T155A P156T |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt23 carried this variant and was unable to recognize the challenge HXB2 form, ALAALITPK. |
Variant ID. | 1684 |
---|---|
Epitope Seq. | ALAALITPK |
Variant Seq. | ALAAvITPK |
Mutations | L/V |
Epitope Location | L5V |
HXB2 Location | L153V |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt43 carried this variant and was unable to recognize the challenge HXB2 form, ALAALITPK. |
Variant ID. | 1685 |
---|---|
Epitope Seq. | ALAALITPK |
Variant Seq. | ALAALvTPK |
Mutations | I/V |
Epitope Location | I6V |
HXB2 Location | I154V |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt17 carried this variant and was unable to recognize the challenge HXB2 form, ALAALITPK. |
Variant ID. | 1686 |
---|---|
Epitope Seq. | ALAALITPK |
Variant Seq. | ALAALIrPK |
Mutations | T/R |
Epitope Location | T7R |
HXB2 Location | T155R |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt33 carried this variant and cross-recognized the challenge HXB2 form, ALAALITPK. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Vif(158-166) | Vif Epitope Map
View variants at this location |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
KIKPPLPSV
|
Epitope Alignment | ||||||||||||||||
Variants |
|
|||||||||||||||||
Epitope Name | VIf 158(2I) | |||||||||||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 5 variant(s).
Variant ID. | 1708 |
---|---|
Epitope Seq. | KIKPPLPSV |
Variant Seq. | KtKPPLPSV |
Mutations | I/T |
Epitope Location | I2T |
HXB2 Location | I159T |
Mutation Type | NSF: non-susceptible form |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt35 and Pt41 carried this HXB2 epitope and did not recognize it; Subjects Pt16, Pt18, Pt23, Pt33, Pt43 carried the 2T variant and did not recognize either this 2T variant or the challenge HXB2. Only Subject Pt30 who also carried the 2T variant was able to cross-recognize the HXB2 epitope, KIKPPLPSV. |
Variant ID. | 1709 |
---|---|
Epitope Seq. | KIKPPLPSV |
Variant Seq. | KrKPPLPSV |
Mutations | I/R |
Epitope Location | I2R |
HXB2 Location | I159R |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt15 carried this variant and was unable to recognize both the 2T variant, KtKPPLPSV, as well as the HXB2 form. Subject Pt17 who carried this variant did not recognize the 2I challenge HXB2 epitope. |
Variant ID. | 1710 |
---|---|
Epitope Seq. | KIKPPLPSV |
Variant Seq. | KriPPLPSV |
Mutations | I/R K/I |
Epitope Location | I2R K3I |
HXB2 Location | I159R K160I |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt17 carried this variant and was not able to recognize the 2T, KtKPPLPSV, variant epitope. |
Variant ID. | 1711 |
---|---|
Epitope Seq. | KIKPPLPSV |
Variant Seq. | rttPPLPSi |
Mutations | K/R I/T K/T V/I |
Epitope Location | K1R I2T K3T V9I |
HXB2 Location | K158R I159T K160T V166I |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt21 carried this variant epitope and was not able to recognize the challenge HXB2 form. |
Variant ID. | 1712 |
---|---|
Epitope Seq. | KIKPPLPSV |
Variant Seq. | rItPPLPSi |
Mutations | K/R K/T V/I |
Epitope Location | K1R K3T V9I |
HXB2 Location | K158R K160T V166I |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt21 carried this variant was not able to recognize the 2T variant form, KTKPPLPSV. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Vpr(34-42) | Vpr Epitope Map
View variants at this location |
|||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
FPRPWLHGL
|
Epitope Alignment | |||||||||||||||||||||||||
Variants |
|
||||||||||||||||||||||||||
Epitope Name | Vpr 34 | ||||||||||||||||||||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 8 variant(s).
Variant ID. | 1713 |
---|---|
Epitope Seq. | FPRPWLHGL |
Variant Seq. | FPRmWLHsL |
Mutations | P/M G/S |
Epitope Location | P4M G8S |
HXB2 Location | P37M G41S |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt15 carried this variant epitope in a regulatory/accessory protein, and recognized the HXB2 epitope FPRPWLHGL. |
Variant ID. | 1714 |
---|---|
Epitope Seq. | FPRPWLHGL |
Variant Seq. | FPRiWLHsL |
Mutations | P/I G/S |
Epitope Location | P4I G8S |
HXB2 Location | P37I G41S |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt23 carried this variant epitope in a regulatory/accessory protein, and recognized the HXB2 epitope FPRPWLHGL. |
Variant ID. | 1715 |
---|---|
Epitope Seq. | FPRPWLHGL |
Variant Seq. | FPPtWLHnL |
Mutations | R/P P/T G/N |
Epitope Location | R3P P4T G8N |
HXB2 Location | R36P P37T G41N |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt16 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope FPRPWLHGL. |
Variant ID. | 1716 |
---|---|
Epitope Seq. | FPRPWLHGL |
Variant Seq. | FPRvWLHnL |
Mutations | P/V G/N |
Epitope Location | P4V G8N |
HXB2 Location | P37V G41N |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt18 carried this variant epitope in a regulatory/accessory protein, and did not recognize the challenge HXB2 epitope FPRPWLHGL. |
Variant ID. | 1717 |
---|---|
Epitope Seq. | FPRPWLHGL |
Variant Seq. | FPRvWLHGL |
Mutations | P/V |
Epitope Location | P4V |
HXB2 Location | P37V |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt21 carried this variant epitope in a regulatory/accessory protein, and did not recognize the challenge HXB2 epitope FPRPWLHGL. |
Variant ID. | 1718 |
---|---|
Epitope Seq. | FPRPWLHGL |
Variant Seq. | FPRiWLHnL |
Mutations | P/I G/N |
Epitope Location | P4I G8N |
HXB2 Location | P37I G41N |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt30, Pt35 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope FPRPWLHGL. |
Variant ID. | 1719 |
---|---|
Epitope Seq. | FPRPWLHGL |
Variant Seq. | FPRtWLHsL |
Mutations | P/T G/S |
Epitope Location | P4T G8S |
HXB2 Location | P37T G41S |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt41 carried this variant epitope in a regulatory/accessory protein, and did not recognize the challenge HXB2 epitope FPRPWLHGL. |
Variant ID. | 1720 |
---|---|
Epitope Seq. | FPRPWLHGL |
Variant Seq. | FPRmWLHnL |
Mutations | P/M G/N |
Epitope Location | P4M G8N |
HXB2 Location | P37M G41N |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt43 carried this variant epitope in a regulatory/accessory protein, and did not recognize the challenge HXB2 epitope FPRPWLHGL. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Vpr(41-49) | Vpr Epitope Map
View variants at this location |
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
SLGQHIYET
|
Epitope Alignment | |||||||||||||||||||
Variants |
|
||||||||||||||||||||
Epitope Name | Vpr 41 | ||||||||||||||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 6 variant(s).
Variant ID. | 1721 |
---|---|
Epitope Seq. | SLGQHIYET |
Variant Seq. | SLGQHIYnT |
Mutations | E/N |
Epitope Location | E8N |
HXB2 Location | E48N |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt15 carried this variant epitope in a regulatory/accessory protein, and did not recognize the challenge HXB2 epitope SLGQHIYET. |
Variant ID. | 1722 |
---|---|
Epitope Seq. | SLGQHIYET |
Variant Seq. | nLGQyIYET |
Mutations | S/N H/Y |
Epitope Location | S1N H5Y |
HXB2 Location | S41N H45Y |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt16, Pt30 carried this variant epitope in a regulatory/accessory protein, and did not recognize the index epitope SLGQHIYET. |
Variant ID. | 1723 |
---|---|
Epitope Seq. | SLGQHIYET |
Variant Seq. | nLGQHIYET |
Mutations | S/N |
Epitope Location | S1N |
HXB2 Location | S41N |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt18, Pt43 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope SLGQHIYET. |
Variant ID. | 1724 |
---|---|
Epitope Seq. | SLGQHIYET |
Variant Seq. | nLGQfIYET |
Mutations | S/N H/F |
Epitope Location | S1N H5F |
HXB2 Location | S41N H45F |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt35 carried this variant epitope in a regulatory/accessory protein, and did not recognize the challenge HXB2 epitope SLGQHIYET. |
Variant ID. | 1725 |
---|---|
Epitope Seq. | SLGQHIYET |
Variant Seq. | SLGQyIYaT |
Mutations | H/Y E/A |
Epitope Location | H5Y E8A |
HXB2 Location | H45Y E48A |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt41 carried this variant epitope in a regulatory/accessory protein, and did not recognize the challenge HXB2 epitope SLGQHIYET. |
Variant ID. | 1726 |
---|---|
Epitope Seq. | SLGQHIYET |
Variant Seq. | gLGQHIYET |
Mutations | S/G |
Epitope Location | S1G |
HXB2 Location | S41G |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt17, Pt21, Pt33 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope SLGQHIYET. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Rev(73-81) | Rev Epitope Map
View variants at this location |
|||||||
---|---|---|---|---|---|---|---|---|---|
Epitope |
LQLPPIERL
|
Epitope Alignment | |||||||
Variants |
|
||||||||
Epitope Name | Rev 73 | ||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 2 variant(s).
Variant ID. | 1688 |
---|---|
Epitope Seq. | LQLPPIERL |
Variant Seq. | fQLPPIERL |
Mutations | L/F |
Epitope Location | L1F |
HXB2 Location | L73F |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt15 carried this variant but was unable to cross-recognize the challenge HXB2 sequence, LQLPPIERL. |
Variant ID. | 1689 |
---|---|
Epitope Seq. | LQLPPIERL |
Variant Seq. | LQLPPlERL |
Mutations | I/L |
Epitope Location | I6L |
HXB2 Location | I78L |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt16, Pt17, Pt18, Pt21, Pt23, Pt30, Pt33, Pt35, Pt41 and Pt43 carried the HXB2 epitope LQLPPLERL; and none were able to cross-recognize the variant LQLPPIERL. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Rev(96-104) | Rev Epitope Map
View variants at this location |
|||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
GMGSPQILV
|
Epitope Alignment | |||||||||||||||||||||||||
Variants |
|
||||||||||||||||||||||||||
Epitope Name | Rev 96 | ||||||||||||||||||||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 8 variant(s).
Variant ID. | 1727 |
---|---|
Epitope Seq. | GMGSPQILV |
Variant Seq. | GvGSPQILV |
Mutations | M/V |
Epitope Location | M2V |
HXB2 Location | M97V |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt16, Pt18, Pt35, Pt41 carried this HXB2 consensus epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope GMGSPQILV. |
Variant ID. | 1728 |
---|---|
Epitope Seq. | GMGSPQILV |
Variant Seq. | GvGSPQIsg |
Mutations | M/V L/S V/G |
Epitope Location | M2V L8S V9G |
HXB2 Location | M97V L103S V104G |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt15 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope GMGSPQILV. |
Variant ID. | 1729 |
---|---|
Epitope Seq. | GMGSPQILV |
Variant Seq. | GvGSPQIsV |
Mutations | M/V L/S |
Epitope Location | M2V L8S |
HXB2 Location | M97V L103S |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt17 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope GMGSPQILV. |
Variant ID. | 1730 |
---|---|
Epitope Seq. | GMGSPQILV |
Variant Seq. | GvGSPQILl |
Mutations | M/V V/L |
Epitope Location | M2V V9L |
HXB2 Location | M97V V104L |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt21 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope GMGSPQILV. |
Variant ID. | 1731 |
---|---|
Epitope Seq. | GMGSPQILV |
Variant Seq. | GvGnPQILV |
Mutations | M/V S/N |
Epitope Location | M2V S4N |
HXB2 Location | M97V S99N |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt33 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope GMGSPQILV. |
Variant ID. | 1732 |
---|---|
Epitope Seq. | GMGSPQILV |
Variant Seq. | GvGnPQvLV |
Mutations | M/V S/N I/V |
Epitope Location | M2V S4N I7V |
HXB2 Location | M97V S99N I102V |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt23 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope GMGSPQILV. |
Variant ID. | 1733 |
---|---|
Epitope Seq. | GMGSPQILV |
Variant Seq. | GvGSPQvLV |
Mutations | M/V I/V |
Epitope Location | M2V I7V |
HXB2 Location | M97V I102V |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt43 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope GMGSPQILV. |
Variant ID. | 1734 |
---|---|
Epitope Seq. | GMGSPQILV |
Variant Seq. | GvGSPeILV |
Mutations | M/V Q/E |
Epitope Location | M2V Q6E |
HXB2 Location | M97V Q101E |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt30 carried this variant epitope in a regulatory/accessory protein, and cross-recognized the HXB2 epitope GMGSPQILV. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Rev(102-110) | Rev Epitope Map
View variants at this location |
|||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
ILVESPAVL
|
Epitope Alignment | |||||||||||||||||||||||||||||||
Variants |
|
||||||||||||||||||||||||||||||||
Epitope Name | Rev 102 | ||||||||||||||||||||||||||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 10 variant(s).
Variant ID. | 1735 |
---|---|
Epitope Seq. | ILVESPAVL |
Variant Seq. | IsgkpcAVL |
Mutations | L/S V/G E/K S/P P/C |
Epitope Location | L2S V3G E4K S5P P6C |
HXB2 Location | L103S V104G E105K S106P P107C |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt15 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope ILVESPAVL. |
Variant ID. | 1736 |
---|---|
Epitope Seq. | ILVESPAVL |
Variant Seq. | ILVEpstVL |
Mutations | S/P P/S A/T |
Epitope Location | S5P P6S A7T |
HXB2 Location | S106P P107S A108T |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt16 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope ILVESPAVL. |
Variant ID. | 1737 |
---|---|
Epitope Seq. | ILVESPAVL |
Variant Seq. | IsVESPtVL |
Mutations | L/S A/T |
Epitope Location | L2S A7T |
HXB2 Location | L103S A108T |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt17 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope ILVESPAVL. |
Variant ID. | 1738 |
---|---|
Epitope Seq. | ILVESPAVL |
Variant Seq. | ILVEhPtiL |
Mutations | S/H A/T V/I |
Epitope Location | S5H A7T V8I |
HXB2 Location | S106H A108T V109I |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt18 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope ILVESPAVL. |
Variant ID. | 1739 |
---|---|
Epitope Seq. | ILVESPAVL |
Variant Seq. | ILlESPtVL |
Mutations | V/L A/T |
Epitope Location | V3L A7T |
HXB2 Location | V104L A108T |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt21 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope ILVESPAVL. |
Variant ID. | 1740 |
---|---|
Epitope Seq. | ILVESPAVL |
Variant Seq. | ILVESPtVL |
Mutations | A/T |
Epitope Location | A7T |
HXB2 Location | A108T |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt33 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope ILVESPAVL. |
Variant ID. | 1741 |
---|---|
Epitope Seq. | ILVESPAVL |
Variant Seq. | ILVEpsAVL |
Mutations | S/P P/S |
Epitope Location | S5P P6S |
HXB2 Location | S106P P107S |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt35 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope ILVESPAVL. |
Variant ID. | 1742 |
---|---|
Epitope Seq. | ILVESPAVL |
Variant Seq. | ILVESPAVi |
Mutations | L/I |
Epitope Location | L9I |
HXB2 Location | L110I |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt41 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope ILVESPAVL. |
Variant ID. | 1743 |
---|---|
Epitope Seq. | ILVESPAVL |
Variant Seq. | vLVEpPpVL |
Mutations | I/V S/P A/P |
Epitope Location | I1V S5P A7P |
HXB2 Location | I102V S106P A108P |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt43 carried this variant epitope in a regulatory/accessory protein, and recognized the HXB2 epitope ILVESPAVL. |
Variant ID. | 1744 |
---|---|
Epitope Seq. | ILVESPAVL |
Variant Seq. | vLVESPAVL |
Mutations | I/V |
Epitope Location | I1V |
HXB2 Location | I102V |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt23 carried this variant epitope in a regulatory/accessory protein, and recognized the HXB2 epitope ILVESPAVL. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Vpu(66-74) | Vpu Epitope Map
View variants at this location |
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
ALVEMGHHA
|
Epitope Alignment | ||||||||||||||||||||||
Variants |
|
|||||||||||||||||||||||
Epitope Name | Vpu 66 | |||||||||||||||||||||||
Species (MHC/HLA) | human |
Showing all: 7 variant(s).
Variant ID. | 1745 |
---|---|
Epitope Seq. | ALVEMGHHA |
Variant Seq. | ALVEMGHHv |
Mutations | A/V |
Epitope Location | A9V |
HXB2 Location | A75V |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | This modified variant, designed to optimize the anchor residue was cross-recognized strongly by index epitope ALVEMGHHA-recognizing CTL. |
Variant ID. | 1746 |
---|---|
Epitope Seq. | ALVEMGHHA |
Variant Seq. | tmVdMGnlr |
Mutations | A/T L/M E/D H/N H/L A/R |
Epitope Location | A1T L2M E4D H7N H8L A9R |
HXB2 Location | A67T L68M E70D H73N H74L A75R |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt15 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope ALVEMGHHA. |
Variant ID. | 1747 |
---|---|
Epitope Seq. | ALVEMGHHA |
Variant Seq. | iLVEMGHdA |
Mutations | A/I H/D |
Epitope Location | A1I H8D |
HXB2 Location | A67I H74D |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt16 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope ALVEMGHHA. |
Variant ID. | 1748 |
---|---|
Epitope Seq. | ALVEMGHHA |
Variant Seq. | gLVEMGHpA |
Mutations | A/G H/P |
Epitope Location | A1G H8P |
HXB2 Location | A67G H74P |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt17 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope ALVEMGHHA. |
Variant ID. | 1749 |
---|---|
Epitope Seq. | ALVEMGHHA |
Variant Seq. | ALVErGylA |
Mutations | M/R H/Y H/L |
Epitope Location | M5R H7Y H8L |
HXB2 Location | M71R H73Y H74L |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt23 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope ALVEMGHHA. |
Variant ID. | 1750 |
---|---|
Epitope Seq. | ALVEMGHHA |
Variant Seq. | iLmEMGHdA |
Mutations | A/I V/M H/D |
Epitope Location | A1I V3M H8D |
HXB2 Location | A67I V69M H74D |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt35 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope ALVEMGHHA. |
Variant ID. | 1751 |
---|---|
Epitope Seq. | ALVEMGHHA |
Variant Seq. | ALmgMGHHA |
Mutations | V/M E/G |
Epitope Location | V3M E4G |
HXB2 Location | V69M E70G |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt41 carried this variant epitope in a regulatory/accessory protein, and did not recognize the HXB2 epitope ALVEMGHHA. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | gp160(67-75) | gp160 Epitope Map
View variants at this location |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
NVWATHACV
|
Epitope Alignment | ||||||||||
Variants |
|
|||||||||||
Epitope Name | Env 67(2V) | |||||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 3 variant(s).
Variant ID. | 10 |
---|---|
Epitope Seq. | NVWATHACV |
Variant Seq. | NiWATHACV |
Mutations | V/I |
Epitope Location | V2I |
HXB2 Location | V68I |
Mutation Type | SF: susceptible form |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt23 carried the challenge HXB2 epitope, and recognized the 2I variant epitope NIWATRACV, while all other Subjects Pt15, Pt16, Pt17, Pt18, Pt21, Pt33, Pt35, Pt41 and Pt43 did not recognize the 2I variant. All of the above subjects, however, also did not recognize the consensus HXB2 epitope that they carried. |
Variant ID. | 1752 |
---|---|
Epitope Seq. | NVWATHACV |
Variant Seq. | NVWATrACV |
Mutations | H/R |
Epitope Location | H6R |
HXB2 Location | H72R |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt30 carried this variant epitope, and did not recognize the challenge HXB2 epitope NIWATRACV. |
Variant ID. | 1753 |
---|---|
Epitope Seq. | NVWATHACV |
Variant Seq. | NiWATrACV |
Mutations | V/I H/R |
Epitope Location | V2I H6R |
HXB2 Location | V68I H72R |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt30 carried this variant epitope, and did not recognize the HXB2 epitope NVWATRACV. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | gp160(121-129) | gp160 Epitope Map
View variants at this location |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
KLTPLCVTL
|
Epitope Alignment | ||||||||||
Variants |
|
|||||||||||
Epitope Name | Env 121 | |||||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 3 variant(s).
Variant ID. | 1761 |
---|---|
Epitope Seq. | KLTPLCVTL |
Variant Seq. | KLTPfCVvL |
Mutations | L/F T/V |
Epitope Location | L5F T8V |
HXB2 Location | L125F T128V |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt30 carried this variant epitope, and did not recognize the challenge HXB2 epitope KLTPLCVTL. |
Variant ID. | 1762 |
---|---|
Epitope Seq. | KLTPLCVTL |
Variant Seq. | KLTPLCVsL |
Mutations | T/S |
Epitope Location | T8S |
HXB2 Location | T128S |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt41 carried the HXB2 epitope KLTPLCVsL, and did not recognize the index epitope KLTPLCVTL. |
Variant ID. | 1763 |
---|---|
Epitope Seq. | KLTPLCVTL |
Variant Seq. | KiTPLCVTL |
Mutations | L/I |
Epitope Location | L2I |
HXB2 Location | L122I |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt43 carried this variant epitope, and did not recognize the challenge HXB2 epitope KLTPLCVTL. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | gp160(529-537) | gp160 Epitope Map
View variants at this location |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
TMGAASITL
|
Epitope Alignment | ||||||||||||||||
Variants |
|
|||||||||||||||||
Epitope Name | Env 529 | |||||||||||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 5 variant(s).
Variant ID. | 1754 |
---|---|
Epitope Seq. | TMGAASITL |
Variant Seq. | TMGAASmTL |
Mutations | I/M |
Epitope Location | I7M |
HXB2 Location | I535M |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt16, Pt21 carried the HXB2 epitope TMGAASmTL, but cross-recognized the variant TMGAASITL; Pt18, Pt43 also carried the consensus HXB2 sequence but failed to recognize the index TMGAASITL. |
Variant ID. | 1755 |
---|---|
Epitope Seq. | TMGAASITL |
Variant Seq. | TMGAASlTL |
Mutations | I/L |
Epitope Location | I7L |
HXB2 Location | I535L |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt35 carried this variant epitope in a structural protein, and did not recognize the challenge HXB2 epitope TMGAASITL. |
Variant ID. | 1756 |
---|---|
Epitope Seq. | TMGAASITL |
Variant Seq. | TMGAASvTL |
Mutations | I/V |
Epitope Location | I7V |
HXB2 Location | I535V |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt41 carried this variant epitope in a structural protein, and recognized the challenge HXB2 epitope TMGAASITL. |
Variant ID. | 1757 |
---|---|
Epitope Seq. | TMGAASITL |
Variant Seq. | TMGAASmaL |
Mutations | I/M T/A |
Epitope Location | I7M T8A |
HXB2 Location | I535M T536A |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt23 carried this variant epitope in a structural protein, and did not recognize the challenge HXB2 epitope TMGAASITL. |
Variant ID. | 1758 |
---|---|
Epitope Seq. | TMGAASITL |
Variant Seq. | TMGAASvaL |
Mutations | I/V T/A |
Epitope Location | I7V T8A |
HXB2 Location | I535V T536A |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt17 carried this variant epitope in a structural protein, and did not recognize the challenge HXB2 epitope TMGAASITL. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | gp160(565-573) | gp160 Epitope Map
View variants at this location |
|||||||
---|---|---|---|---|---|---|---|---|---|
Epitope |
LLQLTVWGI
|
Epitope Alignment | |||||||
Variants |
|
||||||||
Epitope Name | Env 565 | ||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 2 variant(s).
Variant ID. | 1674 |
---|---|
Epitope Seq. | LLQLTVWGI |
Variant Seq. | mLQLTVWGI |
Mutations | L/M |
Epitope Location | L1M |
HXB2 Location | L565M |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt15, Pt18, Pt23 and Pt30 were carriers of this variant and were all unable to recognize the challenge HXB2 epitope, LLQLTVWGI. |
Variant ID. | 1675 |
---|---|
Epitope Seq. | LLQLTVWGI |
Variant Seq. | LLkLTVWGI |
Mutations | Q/K |
Epitope Location | Q3K |
HXB2 Location | Q567K |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt41 was a carrier of this variant and was unable to recognize the challenge HXB2 epitope, LLQLTVWGI. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | gp160(681-689) | gp160 Epitope Map
View variants at this location |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
YIKIFIMIV
|
Epitope Alignment | ||||||||||
Variants |
|
|||||||||||
Epitope Name | Env 681 | |||||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 3 variant(s).
Variant ID. | 1676 |
---|---|
Epitope Seq. | YIKIFIMIV |
Variant Seq. | YIKIFIMIi |
Mutations | V/I |
Epitope Location | V9I |
HXB2 Location | V689I |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt23 and Pt35 were carriers of this variant. Pt23 was able to cross-recognize the consensus HXB2 epitope tested, YIKIFIMIV, but Pt35 was not. Of the 7 subjects who carried the challenge HXB2, YIKIFIMIV, only Pt16 could recognize it. |
Variant ID. | 1677 |
---|---|
Epitope Seq. | YIKIFIMIV |
Variant Seq. | YIrlFIMIV |
Mutations | K/R I/L |
Epitope Location | K3R I4L |
HXB2 Location | K683R I684L |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt17 was a carrier of this variant and was unable to recognize the challenge HXB2 epitope, YIKIFIMIV. |
Variant ID. | 1678 |
---|---|
Epitope Seq. | YIKIFIMIV |
Variant Seq. | YIrIFIMIV |
Mutations | K/R |
Epitope Location | K3R |
HXB2 Location | K683R |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subject Pt41 was a carrier of this variant and was unable to recognize the challenge HXB2 epitope, YIKIFIMIV. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.
HXB2 Location | Nef(141-148) | Nef Epitope Map
View variants at this location |
||||
---|---|---|---|---|---|---|
Epitope |
WCFKLVPV
|
Epitope Alignment | ||||
Variants |
|
|||||
Epitope Name | Nef 141 | |||||
Species (MHC/HLA) | human(A2) |
Showing all: 1 variant(s).
Variant ID. | 1687 |
---|---|
Epitope Seq. | WCFKLVPV |
Variant Seq. | WCyKLVPV |
Mutations | F/Y |
Epitope Location | F3Y |
HXB2 Location | F143Y |
Mutation Type | OV: observed variant |
Method | CD8 T-cell Elispot - IFNy, Flow cytometric T-cell cytokine assay, Sequence |
Note | Subjects Pt15 and Pt16 carried the HXB2 epitope WCYKLVPV; but while Pt15 was able to cross-recognize the challenge variant sequence WCFKLVPV, Pt 16 was not. |
Thorn2007 Mette Thorn, Sheila Tang, Dominic Therrien, Henrik Kløverpris, Lasse Vinner, Gitte Kronborg, Jan Gerstoft, Sylvie Corbet, and Anders Fomsgaard. Sequence Conservation of Subdominant HLA-A2-Binding CTL Epitopes in HIV-1 Clinical Isolates and CD8+ T-Lymphocyte Cross-Recognition May Explain the Immune Reaction in Infected Individuals. APMIS, 115(6):757-768, Jun 2007. PubMed ID: 17550385. Show all entries for this paper.